Scynexis (SCYX) Notes Payables (2018)

Scynexis' (SCYX) quarterly Notes Payables came in at $174000.0 in Q3 2018, down 94.6% on a QoQ basis from $3.2 million in Q2 2018.

Scynexis (SCYX) Notes Payables (2018) Analysis & Trends

Scynexis (SCYX) has 1 years of Notes Payables data on file, last reported at $174000.0 in Q3 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.91 Bn	42.95 Bn	-
2	Teva Pharmaceutical Industries	42.98 Bn	39.32 Bn	2.15 Bn
3	Zoetis	31.53 Bn	29.86 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.61 Bn	22.81 Bn	5.10 Bn
5	United Therapeutics	22.16 Bn	19.49 Bn	683.80 Mn
6	Viatris	18.74 Bn	17.85 Bn	1.46 Bn
7	Neurocrine Biosciences	15.51 Bn	15.12 Bn	935.80 Mn
8	Elanco Animal Health	11.76 Bn	11.23 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.12 Bn	9.95 Bn	-
10	Scynexis	62.02 Mn	-52.68 Mn	-

Download Data